गृहपृष्ठ ∕ Nepal ∕ Indian Covishield becomes first Covid-19 vaccine to get approval in Nepal Nepal Indian Covishield becomes first Covid-19 vaccine to get approval in Nepal The Department of Drug Administration today decided to grant emergency use authorization of Covishield vaccine against Covid-19 in Nepal KathmanduPati January 15, 2021 KATHMANDU – The government has granted the permission for emergency use authorization of Covishield vaccine against Covid-19 in Nepal. The Department of Drug Administration today decided to grant emergency use authorization of Covishield vaccine against Covid-19 in Nepal. Covishied is a Covid-19 vaccine manufactured by India’s Serum Institute of India Pvt Ltd. The decision to grant the approval will pave the way for the entry of Indian coronavirus vaccine in Nepal. Covishield has also become the first Covid-19 vaccine to get the permission for the emergency use in Nepal. Write your comments RELATED NEWS Monthly allowance of Rs.2,000 for unemployed graduates from Madhesh Gold price rises by Rs 900 per tola,silver up Rs… NPL 2025: Biratnagar Kings and Chitwan Rhinos competing today Weather to remain mainly fair today MoFAGA urges local levels to provide details of damage Yadav appointed Chief Minister of Madhesh Province Top Headlines TRENDING Nepal Army initiates investigation into case of financial irregularities by Lieutenant Colonel Janmat Karki Federal Parliament Secretariat returns badge pins to manufacturer Prime Minister Oli’s confidante Prem Kumar Rai recommended as CIAA Chief Commissioner Indian RAW Chief Goel meets Prime Minister Oli after coming to Nepal from Bhutan Strict action against those who abuse health workers: Sajha Party Kathmandu-Hetauda tunnel way construction on priority Six Members Nominamted to National sports council Longer conflict along China borders cannot be discounted, warns Indian Chief of Defence Staff Rawat
